Viscosupplementation Market Growth Accelerated by Rising Prevalence of Osteoarthritis


 Viscosupplementation products are injectable medications used in the treatment of osteoarthritis by supplementing the loss of naturally occurring fluid in arthritic joints. Viscosupplementation help relieve joint pain by lubricating and cushioning the joints. The global viscosupplementation market is estimated to be valued at US$ 3,146.7 Mn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The rising prevalence of osteoarthritis across the globe is the major factor driving the growth of viscosupplementation market. Osteoarthritis is the most common joint disease among the geriatric population. As per International Osteoporosis Foundation, osteoarthritis affects over 300 million people globally. The risk of developing osteoarthritis of the knee increases with age and it has been reported that there will be a 78% increase in the number of individuals with osteoarthritis between 2005 and 2030 solely due to the aging of the population. The increasing geriatric population is leading to the rising prevalence of osteoarthritis which in turn expected to surge the demand for viscosupplementation treatment over the forecast period.
Segment Analysis
The global viscosupplementation market is dominated by hyaluronic acid segment. Hyaluronic acid viscosupplements are the most commonly used viscosupplementation products for knee osteoarthritis. This is because they are found to be very effective in reducing pain and improving joint function. Hyaluronic acid viscosupplements mimic the natural synovial fluid of healthy joints thereby providing lubrication and elasticity within the knee joint.

Key Takeaways

The global viscosupplementation market is expected to witness high growth over the forecast period of 2023 to 2030. Rapid growth in the geriatric population worldwide who are more prone to osteoarthritis is a major factor driving the market. According to WHO estimates, the global geriatric population is expected to reach around 1.5 billion by 2050.

Regional Analysis: North America currently dominates the global viscosupplementation market mainly due to rising incidence of osteoarthritis and presence of major market players in the region. However, Asia Pacific region is expected to show fastest growth owing to growing medical tourism coupled with rising healthcare spending in countries such as India and China.


Key players operating in the viscosupplementation market are Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, and Johnson & Johnson. The key players are involved in new product launches and strategic collaborations to strengthen their market position. For instance, in 2021, Anika Therapeutics launched "MONOVISC", a single-injection hyaluronic acid viscosupplement for treatment of osteoarthritis pain of the knee.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more